MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
marketable securities
$10,659,546
Net cash provided
by/(used in) investing...
$4,740,006
Canceled cashflow
$5,919,540
Net decrease in cash
$34,399
Canceled cashflow
$4,705,607
Purchases of marketable
securities
$5,919,540
Options issued to
directors
$110,168
Options issued to
non-employees
$44,219
Options issued to key
employees
$35,103
Change in fair value of
marketable securities
-$1,744
Net cash used by
operating activities
-$4,705,607
Canceled cashflow
$191,234
Net loss
-$2,920,938
Change in fair value of
derivatives
$1,303,000
Prepaid expenses
$445,773
Trade and other
payables
-$224,954
(gain) on sale of
marketable securities
$2,176
Back
Back
Cash Flow
source: myfinsight.com
TNF Pharmaceuticals, Inc. (TNFA)
TNF Pharmaceuticals, Inc. (TNFA)